November 2015 - OncoMark featured in The Sunday Times

print version

Read about our CEO's experience in the diagnostics industry and his selection of OncoMark as his new venture in the Sunday Times:

Desmond O'Leary was impressed by OncoMarks' proof of concept data for their early stage breast cancer prognostic assay, named OncoMasTR. These data, the strong market opportunity and the experienced team leading the company, first attracted him to OncoMark and led to his appointment as CEO in August 2015.